The Proapoptotic F-box Protein Fbxl7 Regulates Mitochondrial Function by Mediating the Ubiquitylation and Proteasomal Degradation of Survivin*

Background: The SCF ubiquitin E3 ligase component Fbxl7 possesses proapoptotic activity. Results: Fbxl7 targets the antiapoptotic protein survivin for polyubiquitylation and proteasomal degradation. Conclusion: Survivin protects mitochondria from damage induced by Fbxl7. Significance: Understanding how F-box proteins regulate survivin might impact therapies to preserve cellular bioenergetics. Fbxl7, a component of the Skp1·Cul1·F-box protein type ubiquitin E3 ligase, regulates mitotic cell cycle progression. Here we demonstrate that overexpression of Fbxl7 in lung epithelia decreases the protein abundance of survivin, a member of the inhibitor of apoptosis family. Fbxl7 mediates polyubiquitylation and proteasomal degradation of survivin by interacting with Glu-126 within its carboxyl-terminal α helix. Furthermore, both Lys-90 and Lys-91 within survivin serve as ubiquitin acceptor sites. Ectopically expressed Fbxl7 impairs mitochondrial function, whereas depletion of Fbxl7 protects mitochondria from actions of carbonyl cyanide m-chlorophenylhydrazone, an inhibitor of oxidative phosphorylation. Compared with wild-type survivin, cellular expression of a survivin mutant protein deficient in its ability to interact with Fbxl7 (E126A) and a ubiquitylation-resistant double point mutant (KK90RR/KK91RR) rescued mitochondria to a larger extent from damage induced by overexpression of Fbxl7. Therefore, these data suggest that the Skp1·Cul1·F-box protein complex subunit Fbxl7 modulates mitochondrial function by controlling the cellular abundance of survivin. The results raise opportunities for F-box protein targeting to preserve mitochondrial function.

[1]  M. P. Holloway,et al.  Acetylation Directs Survivin Nuclear Localization to Repress STAT3 Oncogenic Activity* , 2010, The Journal of Biological Chemistry.

[2]  Bill B. Chen,et al.  F-box protein FBXL19–mediated ubiquitination and degradation of the receptor for IL-33 limits pulmonary inflammation , 2012, Nature Immunology.

[3]  Y. Liu,et al.  F-box protein Fbxl18 mediates polyubiquitylation and proteasomal degradation of the pro-apoptotic SCF subunit Fbxl7 , 2015, Cell Death and Disease.

[4]  K. Gustafson,et al.  Erioflorin Stabilizes the Tumor Suppressor Pdcd4 by Inhibiting Its Interaction with the E3-ligase β-TrCP1 , 2012, PloS one.

[5]  J. Infante,et al.  Phase I dose-escalation study of LCL161, an oral inhibitor of apoptosis proteins inhibitor, in patients with advanced solid tumors. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[6]  D. Hallahan,et al.  XIAP and survivin as therapeutic targets for radiation sensitization in preclinical models of lung cancer , 2004, Oncogene.

[7]  D. Green,et al.  The BCL-2 family reunion. , 2010, Molecular cell.

[8]  M. Vidal,et al.  Identification of a family of human F-box proteins , 1999, Current Biology.

[9]  Tao Zhang,et al.  A potent and orally active antagonist (SM-406/AT-406) of multiple inhibitor of apoptosis proteins (IAPs) in clinical development for cancer treatment. , 2011, Journal of medicinal chemistry.

[10]  James M. Roberts,et al.  Multisite phosphorylation by Cdk2 and GSK3 controls cyclin E degradation. , 2003, Molecular cell.

[11]  Tony Hunter,et al.  Structural basis for phosphoserine-proline recognition by group IV WW domains , 2000, Nature Structural Biology.

[12]  M. Bertrand,et al.  cIAP1 and cIAP2 facilitate cancer cell survival by functioning as E3 ligases that promote RIP1 ubiquitination. , 2008, Molecular cell.

[13]  Zhiwei Wang,et al.  Roles of F-box proteins in cancer , 2014, Nature Reviews Cancer.

[14]  R. Deshaies,et al.  RING domain E3 ubiquitin ligases. , 2009, Annual review of biochemistry.

[15]  V. Dixit,et al.  Death receptors: signaling and modulation. , 1998, Science.

[16]  Michele Pagano,et al.  Mechanisms and function of substrate recruitment by F-box proteins , 2013, Nature Reviews Molecular Cell Biology.

[17]  J. Noel,et al.  Structure of the human anti-apoptotic protein survivin reveals a dimeric arrangement , 2000, Nature Structural Biology.

[18]  D. Altieri Validating survivin as a cancer therapeutic target , 2003, Nature Reviews Cancer.

[19]  Bill B. Chen,et al.  SCFFbxw15 Mediates Histone Acetyltransferase Binding to Origin Recognition Complex (HBO1) Ubiquitin-Proteasomal Degradation to Regulate Cell Proliferation* , 2013, The Journal of Biological Chemistry.

[20]  Keiji Tanaka,et al.  Fbs2 Is a New Member of the E3 Ubiquitin Ligase Family That Recognizes Sugar Chains* , 2003, Journal of Biological Chemistry.

[21]  M. Pagano,et al.  FBXL2- and PTPL1-mediated degradation of p110-free p85β regulatory subunit controls the PI(3)K signalling cascade , 2013, Nature Cell Biology.

[22]  Michele Pagano,et al.  SCF ubiquitin ligase-targeted therapies , 2014, Nature Reviews Drug Discovery.

[23]  Bill B. Chen,et al.  A combinatorial F box protein directed pathway controls TRAF adaptor stability to regulate inflammation , 2013, Nature Immunology.

[24]  Timothy Cardozo,et al.  The SCF ubiquitin ligase: insights into a molecular machine , 2004, Nature Reviews Molecular Cell Biology.

[25]  J. Harbott,et al.  High Expression Levels of X-Linked Inhibitor of Apoptosis Protein and Survivin Correlate with Poor Overall Survival in Childhood de Novo Acute Myeloid Leukemia , 2004, Clinical Cancer Research.

[26]  R. Mallampalli,et al.  Emerging therapies targeting the ubiquitin proteasome system in cancer. , 2014, The Journal of clinical investigation.

[27]  W. Earnshaw,et al.  Aurora-B Phosphorylation in Vitro Identifies a Residue of Survivin That Is Essential for Its Localization and Binding to Inner Centromere Protein (INCENP) in Vivo* , 2004, Journal of Biological Chemistry.

[28]  Y. Xiong,et al.  CUL9 mediates the functions of the 3M complex and ubiquitylates survivin to maintain genome integrity. , 2014, Molecular cell.

[29]  H. Kawasaki,et al.  E3 ubiquitin ligase that recognizes sugar chains , 2002, Nature.

[30]  J. Hagenbuchner,et al.  BIRC5/Survivin enhances aerobic glycolysis and drug resistance by altered regulation of the mitochondrial fusion/fission machinery , 2013, Oncogene.

[31]  R. Korneluk,et al.  Degradation of Survivin by the X-linked Inhibitor of Apoptosis (XIAP)-XAF1 Complex* , 2007, Journal of Biological Chemistry.

[32]  G. Roth,et al.  Chemical genetics approach to restoring p27Kip1 reveals novel compounds with antiproliferative activity in prostate cancer cells , 2010, BMC Biology.

[33]  L K Miller,et al.  An exegesis of IAPs: salvation and surprises from BIR motifs. , 1999, Trends in cell biology.

[34]  M. Pagano,et al.  Specific small molecule inhibitors of Skp2-mediated p27 degradation. , 2012, Chemistry & biology.

[35]  Simone Fulda,et al.  Targeting IAP proteins for therapeutic intervention in cancer , 2012, Nature Reviews Drug Discovery.

[36]  Bill B. Chen,et al.  Novel E3 ligase component FBXL7 ubiquitinates and degrades Aurora A, causing mitotic arrest , 2012, Cell cycle.

[37]  L. Frati,et al.  Expression and prognostic significance of LIVIN, SURVIVIN and other apoptosis-related genes in the progression of superficial bladder cancer. , 2003, Annals of oncology : official journal of the European Society for Medical Oncology.

[38]  D. Altieri,et al.  A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma , 1997, Nature Medicine.

[39]  Fengzhi Li,et al.  Control of apoptosis and mitotic spindle checkpoint by survivin , 1998, Nature.

[40]  G. Salvesen,et al.  Apoptosis: IAP proteins: blocking the road to death's door , 2002, Nature Reviews Molecular Cell Biology.

[41]  M. Hung,et al.  Pharmacological Inactivation of Skp2 SCF Ubiquitin Ligase Restricts Cancer Stem Cell Traits and Cancer Progression , 2013, Cell.